UK accuses drugmakers and distributor of non-compete agreements
The UK’s competition enforcer has provisionally found that four companies agreed not to compete in the supply of an anti-nausea tablet to the country’s national health service, resulting in a 700% rise in the price.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.